Randomized, Multicenter, Open-label, Parallel Group Study to Evaluate Efficacy and Safety of Combigan(Brimonidine/Timolol) and 0.5% Timoptic(Timolol) Ophthalmic Solutions in Normal Tension Glaucoma Patients

NCT01446497 Phase 4 UNKNOWN

Purpose To evaluate efficacy and safety of combigan(Brimonidine/Timolol) and 0.5% Timoptic (Timolol) ophthalmic solutions in normal tension glaucoma patients.

Details

Lead sponsor	Seoul National University Hospital
Phase	Phase 4
Status	UNKNOWN
Enrolment	22
Start date	2010-10
Completion	2012-08

Conditions

• Normal Tension Glaucoma

Interventions

• Brimonidine/Timolol mixed combination
• Timolol

Primary outcomes

• Change from baseline in intraocular pressure at 12 weeks — 12 weeks after the initial treatment
  Intraocular pressure (IOP) check by Goldmann applanation tonometry with topical anesthetic eyedrop

Countries

South Korea